It is now more than 30 years since the publication of the first definitive epidemiological study by Doll Patients with no major tobacco-related disease as the diagnosis responsible for their current admission were accepted as controls. The major control diagnoses were acute infectious diseases, fractures, and cancers of the colon, rectum, stomach, and prostate and neoplasms of the lymphatic and haematopoetic tissue. No one disease group exceeded 10% of the total number of controls. Both case and control patients were interviewed in hospital by one of two specially trained interviewers. Arrangements were made to ensure, as far as possible, that the interviewers had no knowledge of the diagnosis from members of staff nor access to the case record. A standard questionnaire' was used to record and investigate the nature of present and past cigarette use, with particular emphasis on recording changes in the number of cigarettes, smoked, years of usage, and changes in brands during the smoker's lifetime, so as to provide the best possible estimate of exposure during lifetime up to the time of interview.
The age and social class distribution of cases and controls is given in table 1.
The most commonly used statistic in the literature to describe exposure to cigarette tobacco products is the average number of cigarettes smoked per day, and the most frequently used expression of risk, in terms of disease, is the relative risk. Average number of cigarettes per day has been based on the total amount smoked throughout the smoking lifetime. Relative risk has been estimated taking the matching of controls to cases into account. 5 The questionnaire permitted further measures of cigarette exposure to be described, namely: 1 an estimate of the total number of cigarettes 40 small increase in relative risk to 9-7 and falls among those who reported smoking more than 50 cigarettes daily on average. The dose-response relation, that is, the increase in relative risk with increase in cigarette consumption, for those cases histologically confirmed is shown in figure 1 . The sharp rise in risk for those smoking up to 15-24 cigarettes daily is apparent for both squamous and oat cell tumours. Above this level the flattening of the dose-response curve occurs for those with squamous cell cancer and declines (but not statistically significantly) for oat cell cancers. A relatively weak relation for those with adenocarcinomatous tumours is also shown. Figure 2 shows the relative risk of lung cancer for smokers of 25 cigarettes and more, for those who Table 5 shows the average tar exposure in relation to the quantity of cigarettes smoked by the cases and controls. The percentage of those with high tar exposure among heavy smokers is similar in cases and controls. Table 6 presents the reported inhalation of smokers in relation to the quantity of cigarettes smoked for both cases and controls. Smokers of less than 15 cigarettes per day seem less likely to be deep inhalers in contrast to the heavier smoking categories. Over 40% of smokers who smoked 25 or more cigarettes per day said they inhaled deeply. Figure 3 shows the relative risk of lung cancer for the 140 cases and 350 controls who stopped smoking completely for periods ranging from one to 20 years relative to their average consumption before stopping. The pattern ofdeclining risk with stopping smoking is similar for each group of smokers (the first point on fig 3 shows the relative risk of present smokers as in .N 7. table 2). Only those who reported stopping smoking for at least five years or more show a decline in relative risk.
Discussion
The major finding in this study is the steep increase in the relative risk of lung cancer observed in West of Scotland smokers with an average consumption of 42 1-14 and 15-24 cigarettes daily, compared with the small increase in relative risk in smokers with a higher average daily consumption (table 2) . This is at variance with the majority of the literature which describes a steady increase in relative risk above an average consumption of 20 cigarettes daily. The validity ofthe findings in this study is supported by the following: 1 The procedures followed in this study are accepted as current practice in the design of case-control studies.8 The median age of cases interviewed in the study was younger than in the West of Scotland generally. The control diagnoses were spread over a wide spectrum of non-smoking related diseases with no single control disease exceeding 10% of the total. Although a period of five years was allowed in matching the age at diagnosis of cases and controls, 82-5% fell within three years. The distribution of cell types was similar to that in previous studies although the rate of histological confirmation was somewhat lower. 2 The questionnaire used in this study has been used in many studies of smoking and disease over the past 30 years. Some 50 interviews were repeated by chance during the course of the study. Of these, 48 gave answers regarding cigarette consumption, which, when allocated to smoking exposure categories, were the same as previously given. 3 Variation between interviewers and the quality of the interviews conducted could be closely monitored throughout the study as only two interviewers were responsible for 95% of the interviews. Considerable care was also taken to ensure that they had no knowledge of the diagnosis. 4 The majority of the well known epidemiological associations of cigarette smoking and lung cancer can be reproduced using the data collected in this study; a decrease in relative risk in ex-smokers after five years since stopping9 ( fig 3) ; squamous and oat cell tumours associated with the highest levels of relative risk whereas adenocarcinomas showing only a minor association with cigarette smokingl 11 (fig 1) ; a significant positive association between depth of inhalation and average daily consumption of cigarettes. 12 The results of this study raise three main questions. The possibility also exists that average number of cigarettes per day does not provide an adequate estimation of total dose although this has often been used in the literature. Total lifetime packets, which incorporates the number of years of smoking, and total tar yield also produce a flattening of the doseresponse relation at the higher levels of exposure.
Total tar yield is probably the best measure of exposure statistically. There was no increase in relative risk for smokers of 25 cigarettes per day and above whether they smoked high, medium/high or medium tar cigarettes. An increase in relative risk was present for smokers of 15-24 cigarettes per day for increasing levels of tar exposure but the increase in risk was not statistically significant. Only those who smoked 1-14 cigarettes per day showed a statistically significant reduction in relative risk as tar exposure declined from high to medium.
Thus, in an area of exceptionally high lung cancer incidence, there is a lack of increase of the relative risk of lung cancer at higher levels of cigarette smoking. We have been unable to explain this observation on the basis of confounding bias or artefact.
The low level of relative risk found at all levels of cigarette consumption coupled with the small increase in relative risk observed at the highest levels of smoking represent a paradox for an area with such a very high rate of lung cancer.
The existence ofa higher than average proportion of heavy smokers in the West of Scotland population would not seem therefore sufficient by itself to be responsible for the high lung cancer rate. Thus the question of additional susceptibility to lung cancer in
